Showing 3,221 - 3,240 results of 6,719 for search '"Diabetes"', query time: 0.09s Refine Results
  1. 3221

    Association of predicted fat mass, predicted lean mass and predicted percent fat with diabetes mellitus in Chinese population: a 15-year prospective cohort by Lu Liu, Xiaoping Chen, Chao Ban, Shanshan Jia, Sen He

    Published 2022-06-01
    “…People suffering from DM at baseline (n=24) were excluded, and 687 non-diabetics with complete data were included to the analysis.Primary outcome New-onset DM.Results After the follow-up, 74 (48 men and 26 women) incidences of DM were documented. …”
    Get full text
    Article
  2. 3222
  3. 3223

    Therapeutic Effects of Milk Thistle (Silybum marianum L.) and Artichoke (Cynara scolymus L.) on Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Rats by Aida Doostkam, Mohammad Fathalipour, Mohammad Hossein Anbardar, Azar Purkhosrow, Hossein Mirkhani

    Published 2022-01-01
    “…The present study investigated the protective effects and possible mechanisms of milk thistle (Silybum marianum L.) and artichoke (Cynara scolymus L.) in treating NAFLD in type 2 diabetic rats. Methods. The NAFLD was established in rats after four weeks of type 2 diabetes induction. …”
    Get full text
    Article
  4. 3224
  5. 3225
  6. 3226
  7. 3227
  8. 3228

    Evaluation of Tumour Necrosis Factor Alpha, Interleukin-2 Soluble Receptor, Nitric Oxide Metabolites, and Lipids as Inflammatory Markers in Type 2 Diabetes Mellitus

    Published 2006-01-01
    “…This study indicates that increased level of proinflammatory markers occurs in type 2 DM even in the absence of obesity and marked hyperglycaemia, confirming that the inflammation course of the atherosclerotic process is more severe in diabetic patients than in nondiabetic subjects.</p>…”
    Get full text
    Article
  9. 3229

    Prevalence of non-alcoholic fatty liver disease at obesity and its interrelation with cardio-vascular disease and 2nd type diabetes mellitus risk factors by G. A. Melnichenko, A. Yu. Yeliseyeva, M. V. Mayevskaya

    Published 2012-04-01
    “…To estimate prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with obesity and to determine its interrelation with cardiometabolic risk factors of cardio-vascular diseases (CVD) and diabetes mellitus of the 2nd type (type 2 DM).Material and methods. …”
    Get full text
    Article
  10. 3230
  11. 3231
  12. 3232
  13. 3233
  14. 3234

    Hyperglycemia in Streptozotocin-Induced Diabetes Leads to Persistent Inflammation and Tissue Damage Following Uveitis Due to Reduced Levels of Ciliary Body Heme Oxygenase-1 by Settimio Rossi, Michele D'Amico, Annalisa Capuano, Mary Romano, Pasquale Petronella, Clara Di Filippo

    Published 2006-01-01
    “…This study investigated the heme oxygenase-1 (HO-1) and the endotoxin-induced uveitis (EIU) in diabetic streptozotocin (STZ)-hyperglycemic rats. STZ-hyperglycemic rats had impaired levels of the enzyme HO-1 within the ciliary bodies if compared with the nondiabetic rats. …”
    Get full text
    Article
  15. 3235

    Evaluation of Antidiabetic Properties of the Leaves Extract of Ficus vallis-choudae Delile in a Model of Type 2 Diabetes Induced by High-Fat Diet and Streptozotocin by Kilenma Kolefer, David Miaffo, Roger Ponka

    Published 2021-01-01
    “…This work aimed to determine the phytochemical composition of the aqueous extract of leaves of Ficus vallis-choudae (AEFV) and to evaluate its antidiabetic properties on a model of type 2 diabetes induced by a high-fat diet (HFD) and a low dose of streptozotocin (STZ). …”
    Get full text
    Article
  16. 3236

    A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes by Mark J. Cziraky, Scott Abbott, Matt Nguyen, Kay Larholt, Elizabeth Apgar, Thomas Wasser, Poul Strange, Leon Shi, H. Courtenay Harrison, Beverly Everitt, Lynn Nowak

    Published 2019-03-01
    “…**Background:** Many patients with type 2 diabetes mellitus (T2DM) do not have adequate glycemic control, leading to poor patient outcomes and high healthcare costs. …”
    Get full text
    Article
  17. 3237
  18. 3238
  19. 3239
  20. 3240

    The Impact of C-Peptide and Diabetes Mellitus on Coronary Ectasia and Effect of Coronary Ectasia and C-Peptide on Long-Term Outcomes: A Retrospective Cohort Study by Kenan Toprak, Mustafa Kaplangoray, Ali Palice

    Published 2022-01-01
    “…This study aimed to reveal the impact of C-peptide and diabetes mellitus (DM) on CAE and the effect of C-peptide and coronary ectasia on long-term outcomes in patients who underwent coronary angiography. …”
    Get full text
    Article